FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043763023> ?p ?o ?g. }

• W3043763023 endingPage "626" @default.
• W3043763023 startingPage "617" @default.
• W3043763023 abstract "Background/Aims: Standard approaches to trial design and analyses can be inefficient and non-pragmatic. Failure to consider a range of outcomes impedes evidence-based interpretation and reduces power. Traditional approaches synthesizing information obtained from separate analysis of each outcome fail to incorporate associations between outcomes and recognize the cumulative nature of outcomes in individual patients, suffer from competing risk complexities during interpretation, and since efficacy and safety analyses are often conducted on different populations, generalizability is unclear. Pragmatic and efficient approaches to trial design and analyses are needed. Methods: Approaches providing a pragmatic assessment of benefits and harms of interventions, summarizing outcomes experienced by patients, and providing sample size efficiencies are described. Ordinal outcomes recognize finer gradations of patient responses. Desirability of outcome ranking is an ordinal outcome combining benefits and harms within patients. Analysis of desirability of outcome ranking can be based on rank-based methodologies including the desirability of outcome ranking probability, the win ratio, and the proportion in favor of treatment. Partial credit analyses, involving grading the levels of the desirability of outcome ranking outcome similar to an academic test, provides an alternative approach. The methodologies are demonstrated using the acute stroke or transient ischemic attack treated with aspirin or ticagrelor and patient outcomes study (SOCRATES; NCT01994720), a randomized clinical trial. Results: Two 5-level ordinal outcomes were developed for SOCRATES. The first was based on a modified Rankin scale. The odds ratio is 0.86 (95% confidence interval = 0.75, 0.99; p = 0.04) indicating that the odds of worse stroke categorization for a trial participant assigned to ticagrelor is 0.86 times that of a trial participant assigned to aspirin. The 5-level desirability of outcome ranking outcome incorporated and prioritized survival; the number of strokes, myocardial infarction, and major bleeding events; and whether a stroke event was disabling. The desirability of outcome ranking probability and win ratio are 0.504 (95% confidence interval = 0.499, 0.508; p = 0.10) and 1.11 (95% confidence interval = 0.98, 1.26; p = 0.10), respectively, implying that the probability of a more desirable result with ticagrelor is 50.4% and that a more desirable result occurs 1.11 times more frequently on ticagrelor versus aspirin. Conclusion: Ordinal outcomes can improve efficiency through required pre-specification, careful construction, and analyses. Greater pragmatism can be obtained by composing outcomes within patients. Desirability of outcome ranking provides a global assessment of the benefits and harms that more closely reflect the experience of patients. The desirability of outcome ranking probability, the proportion in favor of treatment, the win ratio, and partial credit can more optimally inform patient treatment, enhance the understanding of the totality of intervention effects on patients, and potentially provide efficiencies over standard analyses. The methods provide the infrastructure for incorporating patient values and estimating personalized effects." @default.
• W3043763023 created "2020-07-23" @default.
• W3043763023 creator A5001594817 @default.
• W3043763023 creator A5001798559 @default.
• W3043763023 creator A5009588075 @default.
• W3043763023 creator A5017144100 @default.
• W3043763023 creator A5023091399 @default.
• W3043763023 creator A5035315133 @default.
• W3043763023 creator A5040093844 @default.
• W3043763023 creator A5042534277 @default.
• W3043763023 creator A5048393176 @default.
• W3043763023 creator A5065999911 @default.
• W3043763023 creator A5066009203 @default.
• W3043763023 creator A5073434872 @default.
• W3043763023 creator A5079323612 @default.
• W3043763023 creator A5089384391 @default.
• W3043763023 date "2020-07-15" @default.
• W3043763023 modified "2023-09-23" @default.
• W3043763023 title "Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial" @default.
• W3043763023 cites W1933023737 @default.
• W3043763023 cites W1992165995 @default.
• W3043763023 cites W2000457925 @default.
• W3043763023 cites W2034514998 @default.
• W3043763023 cites W2035197312 @default.
• W3043763023 cites W2035935210 @default.
• W3043763023 cites W2051910688 @default.
• W3043763023 cites W2085498679 @default.
• W3043763023 cites W2105084079 @default.
• W3043763023 cites W2142030374 @default.
• W3043763023 cites W2149609023 @default.
• W3043763023 cites W2160784493 @default.
• W3043763023 cites W2168905981 @default.
• W3043763023 cites W2357799703 @default.
• W3043763023 cites W2361921955 @default.
• W3043763023 cites W2560710930 @default.
• W3043763023 cites W2726342676 @default.
• W3043763023 cites W2766370714 @default.
• W3043763023 cites W2779726076 @default.
• W3043763023 cites W2896665945 @default.
• W3043763023 cites W2948445695 @default.
• W3043763023 cites W2968886483 @default.
• W3043763023 cites W2986664984 @default.
• W3043763023 cites W2996412902 @default.
• W3043763023 cites W305286142 @default.
• W3043763023 doi "https://doi.org/10.1177/1740774520941441" @default.
• W3043763023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32666831" @default.
• W3043763023 hasPublicationYear "2020" @default.
• W3043763023 type Work @default.
• W3043763023 sameAs 3043763023 @default.
• W3043763023 citedByCount "11" @default.
• W3043763023 countsByYear W30437630232020 @default.
• W3043763023 countsByYear W30437630232021 @default.
• W3043763023 countsByYear W30437630232022 @default.
• W3043763023 countsByYear W30437630232023 @default.
• W3043763023 crossrefType "journal-article" @default.
• W3043763023 hasAuthorship W3043763023A5001594817 @default.
• W3043763023 hasAuthorship W3043763023A5001798559 @default.
• W3043763023 hasAuthorship W3043763023A5009588075 @default.
• W3043763023 hasAuthorship W3043763023A5017144100 @default.
• W3043763023 hasAuthorship W3043763023A5023091399 @default.
• W3043763023 hasAuthorship W3043763023A5035315133 @default.
• W3043763023 hasAuthorship W3043763023A5040093844 @default.
• W3043763023 hasAuthorship W3043763023A5042534277 @default.
• W3043763023 hasAuthorship W3043763023A5048393176 @default.
• W3043763023 hasAuthorship W3043763023A5065999911 @default.
• W3043763023 hasAuthorship W3043763023A5066009203 @default.
• W3043763023 hasAuthorship W3043763023A5073434872 @default.
• W3043763023 hasAuthorship W3043763023A5079323612 @default.
• W3043763023 hasAuthorship W3043763023A5089384391 @default.
• W3043763023 hasConcept C105795698 @default.
• W3043763023 hasConcept C126322002 @default.
• W3043763023 hasConcept C144237770 @default.
• W3043763023 hasConcept C148220186 @default.
• W3043763023 hasConcept C154945302 @default.
• W3043763023 hasConcept C156957248 @default.
• W3043763023 hasConcept C15744967 @default.
• W3043763023 hasConcept C162118730 @default.
• W3043763023 hasConcept C162324750 @default.
• W3043763023 hasConcept C189430467 @default.
• W3043763023 hasConcept C27158222 @default.
• W3043763023 hasConcept C33923547 @default.
• W3043763023 hasConcept C41008148 @default.
• W3043763023 hasConcept C44249647 @default.
• W3043763023 hasConcept C71924100 @default.
• W3043763023 hasConceptScore W3043763023C105795698 @default.
• W3043763023 hasConceptScore W3043763023C126322002 @default.
• W3043763023 hasConceptScore W3043763023C144237770 @default.
• W3043763023 hasConceptScore W3043763023C148220186 @default.
• W3043763023 hasConceptScore W3043763023C154945302 @default.
• W3043763023 hasConceptScore W3043763023C156957248 @default.
• W3043763023 hasConceptScore W3043763023C15744967 @default.
• W3043763023 hasConceptScore W3043763023C162118730 @default.
• W3043763023 hasConceptScore W3043763023C162324750 @default.
• W3043763023 hasConceptScore W3043763023C189430467 @default.
• W3043763023 hasConceptScore W3043763023C27158222 @default.
• W3043763023 hasConceptScore W3043763023C33923547 @default.
• W3043763023 hasConceptScore W3043763023C41008148 @default.
• W3043763023 hasConceptScore W3043763023C44249647 @default.

• next